Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Axonics Modulation Technologies (AXNX)
NASDAQ:AXNX
RESEARCH TOOLSreports
Holding AXNX?
Track your performance easily
AXNX Stock Chart & Stats
Day’s Range$70.37 - $71.05
52-Week Range― - ―
Previous Close$70.45
Volume4.23M
Average Volume (3M)N/A
Market Cap
$3.63B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding51,109,154
10 Day Avg. Volume755,776
30 Day Avg. Volume580,991
Standard Deviation0.12
R-Squared0.14
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)5.46
Price to Sales (P/S)8.40
Price to Cash Flow (P/CF)983.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$71.00Price Target Upside0.03% Upside
Rating ConsensusHold
Number of Analyst Covering2
Axonics Modulation Technologies News
PremiumCompany Announcements
Axonics Modulation Technologies Merges and Delists from Nasdaq
PremiumCompany Announcements
Axonics’ Q3 2024: Revenue Growth Amid Challenges
Ownership Overview
― Insiders
22.99% Mutual Funds
29.34% Other Institutional Investors
28.95% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AXNX FAQ
What was Axonics Modulation Technologies’s price range in the past 12 months?
Currently, no data Available
What is Axonics Modulation Technologies’s market cap?
Currently, no data Available
When is Axonics Modulation Technologies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Axonics Modulation Technologies’s earnings last quarter?
Currently, no data Available
Is Axonics Modulation Technologies overvalued?
According to Wall Street analysts Axonics Modulation Technologies’s price is currently Undervalued.
Does Axonics Modulation Technologies pay dividends?
Axonics Modulation Technologies does not currently pay dividends.
What is Axonics Modulation Technologies’s EPS estimate?
Axonics Modulation Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Axonics Modulation Technologies have?
Currently, no data Available
What happened to Axonics Modulation Technologies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Axonics Modulation Technologies?
Among the largest hedge funds holding Axonics Modulation Technologies’s share is Soros Fund Mangment LLC. It holds Axonics Modulation Technologies’s shares valued at 124M.
---
Axonics Modulation Technologies Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$71.00 (0.03% Upside)
$71.00 (0.03% Upside)
Blogger Sentiment
Bullish
AXNX Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Sold Shares
Worth $205.5K over
the Last 3 Months
the Last 3 Months
Fundamentals
Return on Equity
-0.89%
Trailing 12-Months
Asset Growth
17.17%
Trailing 12-Months
Company Description
Axonics Modulation Technologies
Axonics Modulation Technologies, Inc. operates as a medical technology company, which engages in the design, development, and commercialization of sacral neuromodulation solutions. The firm focuses on the treatment of patients with overactive bladder (OAB), fecal incontinence (FI), and urinary retention (UR). It offers rechargeable SNM system, which delivers mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of OAB, FI, and UR. The company was founded by Guang Qiang Jiang, Danny L. Dearen, Timothy Deer, and Michael V. Williamson in March 2012 and is headquartered in Irvine, CA.
---
AXNX Stock 12 Month Forecast
Average Price Target
$71.00
▲(0.03% Upside)
Technical Analysis
---